MarketPulse

Boston Scientific

26 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Boston Scientific Faces Securities Fraud Lawsuit as Stock Plunges 17% on Guidance Miss

Three companies face class action lawsuits alleging securities fraud. Boston Scientific stock fell 17% after missing earnings guidance amid alleged false revenue projections.
SNOWBSXEOSEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Boston Scientific Faces Class Action Over Alleged Electrophysiology Misstatements

Class action filed against $BSX alleging executives misrepresented U.S. electrophysiology segment sustainability. Claims executives concealed adverse trends, competitive pressures, regulatory challenges.
BSXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Boston Scientific Faces Class Action Over Alleged Electrophysiology Misstatements

Class action lawsuit filed against $BSX alleging executives made false statements about U.S. electrophysiology segment sustainability, concealing competitive pressures and regulatory headwinds.
BSXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Boston Scientific Faces Securities Class Action Over Electrophysiology Misstatements

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability, resulting in earnings miss and weak guidance.
CRWVQUREBSXsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Eric Volkman

Boston Scientific Poised for 5X Growth as Aging Demographics Drive Demand

Boston Scientific positioned to capitalize on global aging through AFib, chronic pain, and Parkinson's treatments; recent acquisitions boost stroke capabilities.
BSXPENhealthcarevaluation
GlobeNewswire Inc.GlobeNewswire Inc.··The Portnoy Law Firm

Boston Scientific Faces Securities Fraud Investigation After Electrophysiology Miss

Boston Scientific faces securities fraud investigation after 17.6% stock drop triggered by weaker-than-expected electrophysiology division sales in Q4 2025 results.
BSXsecurities fraudclass action lawsuit